<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2014</volume><submitter>Chua HR</submitter><pubmed_abstract>The impact of isoosmolar versus low-osmolar contrast media (CM) administration on contrast-induced acute kidney injury (CI-AKI) and extended renal dysfunction (ERD) is unclear. We retrospectively examined incidences of CI-AKI and ERD in patients who received iodixanol (isoosmolar) versus iohexol (low-osmolar) during angiography for cardiac indications. Of 713 patients, 560 (cohort A), 190 (cohort B), and 172 (cohort C) had serum creatinine monitored at 3 days, 30 days, and 6 months after angiography, respectively. 18% of cohort A developed CI-AKI, which was more common with iodixanol than iohexol (22% versus 13%, P = 0.006). However, patients given iodixanol were older with lower baseline estimated glomerular filtration rates (eGFR). On multivariate analysis, independent associations with </pubmed_abstract><journal>BioMed research international</journal><pagination>506479</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4142278</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.</pubmed_title><pmcid>PMC4142278</pmcid><pubmed_authors>Bellomo R</pubmed_authors><pubmed_authors>Horrigan M</pubmed_authors><pubmed_authors>Mcintosh E</pubmed_authors><pubmed_authors>Chua HR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.</name><description>The impact of isoosmolar versus low-osmolar contrast media (CM) administration on contrast-induced acute kidney injury (CI-AKI) and extended renal dysfunction (ERD) is unclear. We retrospectively examined incidences of CI-AKI and ERD in patients who received iodixanol (isoosmolar) versus iohexol (low-osmolar) during angiography for cardiac indications. Of 713 patients, 560 (cohort A), 190 (cohort B), and 172 (cohort C) had serum creatinine monitored at 3 days, 30 days, and 6 months after angiography, respectively. 18% of cohort A developed CI-AKI, which was more common with iodixanol than iohexol (22% versus 13%, P = 0.006). However, patients given iodixanol were older with lower baseline estimated glomerular filtration rates (eGFR). On multivariate analysis, independent associations with </description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-04-26T09:10:08.343Z</modification><creation>2019-03-27T01:34:34Z</creation></dates><accession>S-EPMC4142278</accession><cross_references><pubmed>25180184</pubmed><doi>10.1155/2014/506479</doi></cross_references></HashMap>